Experience | Leaflets | Medicines | Patient+ | Guidelines | News | Products | Other
This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Breakthrough Bleeding with Combined Hormonal Contraception
Post your experienceMost women find that combined hormonal contraception (CHC) provides reliable cycle control.
Indeed the combined oral contraceptive pill (COCP) is often prescribed for the management of menstrual disorders such as menorrhagia and dysfunctional uterine bleeding.1
However, although new formulations with low doses of oestrogen offer health benefits they may provide less satisfactory cycle control.2 The risk of bleeding may also be related to the dose and type of progestogen. Unfortunately, methodological differences between studies have also made it difficult to compare rates of breakthrough bleeding between different preparations.1
Irregular bleeding whilst taking CHC is a common problem3 with up to 30% of women experiencing breakthrough bleeding or spotting during the first cycle of treatment.4 Such bleeding occurs unpredictably5 and may cause significant disruption and anxiety for users.6 Irregular bleeding is thus one of the most common reasons for discontinuation of CHC.7
Normal endometrial maturation depends on complex interactions between oestrogen and progesterone. CHC provides a continuous supply of oestrogen and progestogen to the endometrium. The low dose of oestrogen in modern CHCs is insufficient to maintain endometrial integrity4 and the opposing effect of progestogen promotes atrophy of glands and stroma. The resulting endometrium is thin, fragile and prone to bleeding.1
No relationship has been identified between serum steroid levels and bleeding.8 In the absence of missed or late pills, vomiting or drug interactions, reduced contraceptive efficacy has not been proven.3
Patient factors1
- Poor compliance with medication is the most likely cause of irregular bleeding.
- Cigarette smoking has anti-oestrogenic properties and may affect cycle control.
CHC formulation factors
- COCPs containing only 20 mcg of ethinyloestradiol cause more disrupted bleeding patterns than those containing higher doses.9
- Monophasic and biphasic formulations provide similar cycle control.10
- Triphasic formulations may offer better cycle control.
- First generation progestogens e.g. norethisterone, provide poorer cycle control than second (levonorgestrel) and third generation progestogens.11
- Of third generation progestogens, gestodene may afford better cycle control than desogestrel.12
- CHC patches are associated with more irregular bleeding than COCPs during initial treatment, but rates are similar after three months of use.13
Recommendations to prevent bleeding
- Use COCPs containing 30 mcg of ethinyloestradiol combined with a second generation progestogen as first-choice.
- There is no evidence that starting CHC mid-cycle reduces the incidence of bleeding.14
There are few comparable evidenced-based studies on which to base the management of women experiencing poor cycle control with CHC. The following guidance may be useful:
|
Other considerations
Although CHC is a common cause of irregular bleeding, other unrelated causes must also be considered such as:4
- Chlamydia or other sexually transmitted infections
- Intrauterine or ectopic pregnancy3
- Endometrial or cervical polyp4
- Cervical cancer3
- Endocrine abnormalities such as hypothyroidism, hyperthyroidism, hyperprolactinaemia
- Bleeding disorders4
Document references
- No authors listed; Ovarian and endometrial function during hormonal contraception. Hum Reprod. 2001 Jul;16(7):1527-35. [abstract]
- Kaunitz AM; Enhancing oral contraceptive success: the potential of new formulations. Am J Obstet Gynecol. 2004 Apr;190(4 Suppl):S23-9. [abstract]
- Contraception, Clinical Knowledge Summaries (2007)
- Schrager S; Abnormal uterine bleeding associated with hormonal contraception. Am Fam Physician. 2002 May 15;65(10):2073-80. [abstract]
- WHO (HRP); Rogers A. Progress in Reproductive Health Research. How does progestogen cause endometrial bleeding. 1999.
- Hickey M, Fraser IS; Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding. Hum Reprod. 2002 Sep;17(9):2428-34. [abstract]
- Ansbacher R; Low-dose oral contraceptives: health consequences of discontinuation. Contraception. 2000 Dec;62(6):285-8. [abstract]
- First prescription of combined oral contraception, Faculty of Family Planning and Reproductive Health Care (2006)
- Gallo MF, Nanda K, Grimes DA, et al; 20 mcg versus>20 mcg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003989. [abstract]
- Van Vliet HA, Grimes DA, Helmerhorst FM, et al; Biphasic versus monophasic oral contraceptives for contraception. Cochrane Database Syst Rev. 2006 Jul 19;3:CD002032. [abstract]
- Maitra N, Kulier R, Bloemenkamp KW, et al; Progestogens in combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2004;(3):CD004861. [abstract]
- The Faculty of Family Planning and Reproductive Health Care
- FPRHC Clinical Effectiveness Unit; New product review: Norelgestromin/ ethinyl oestradiol transdermal contraceptive system (Evra). Faculty of Family Planning and Reproductive Health Care. 2003.
- Yeshaya A, Orvieto R, Kaplan B, et al; Flexible starting schedule for oral contraception: effect on the incidence of breakthrough bleeding and compliance. Eur J Contracept Reprod Health Care. 1998 Sep;3(3):121-3. [abstract]
- Van Vliet HA, Grimes DA, Helmerhorst FM, et al; Biphasic versus triphasic oral contraceptives for contraception. Cochrane Database Syst Rev. 2006 Jul 19;3:CD003283. [abstract]
- Wagstaff AJ; Continuous-use ethinylestradiol/levonorgestrel 20microg/90microg: as an oral contraceptive. Drugs. 2007;67(16):2473-7; discussion 2478-9. [abstract]
- Coffee AL, Sulak PJ, Kuehl TJ; Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception. 2007 Jun;75(6):444-9. Epub 2007 Mar 23. [abstract]
Internet and further reading
- WHO World Health Organization, 2004. Selected practice recommendations for contraceptive use
. - Department of Health; Revised guidance for health professionals on the provision of contraceptive services for under 16s (July 2004).
DocID: 515
Document Version: 6
DocRef: bgp25247
Last Updated: 5 Dec 2008
Review Date: 5 Dec 2010
The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.
Patient UK Hearing Impairment Survey
Patient UK are grateful to the 550 people who took part in this survey.
To see the results click here.
If you'd like to leave your feedback, please go to our interactive forum.
Experience | Leaflets | Medicines | Patient+ | Guidelines | News | Products | Other
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineHealth Topic information leaflets related to this topic (^ top of page)
Combined Oral Contraceptive Pill
Migraine and the Contraceptive Pill and PatchMedicine & Drug information leaflets related to this topic (^ top of page)
Combined hormonal contraceptivesPatientPlus articles related to this topic (^ top of page)
Abnormal Menstruation
Combined Hormone Contraception and HRT (Risks vs Benefits)
Combined Oral Contraceptive (First Prescription)
Combined Oral Contraceptive (Follow-up and Common Problems)
Dysfunctional Uterine Bleeding
Intermenstrual and Post-coital Bleeding
Missed Contraceptive Pills
Normal Menstruation
Pill Questions - What to Ask When Starting the OCP.
Postpartum ContraceptionUK guidelines related to this topic (^ top of page)
Guidelines on Combined Oral Contraceptives (coc)Patient UK Newspaper (^ top of page)
Recent related news items
Condom reaches pill's popularity
Has the Pill shaped Hollywood?
The Pill 'affects choice of partner'
Pill choice affects clot risk
Many women 'not on safest pill'Latest Health News
View current health newsRelated Products (^ top of page)
Medical equipment
Pill/Tablet Equipment
Books
The Pill and Other Forms of Hormonal Contraception: The Facts
Other - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites
Want to search some more? Use the Google Search box below to search our site.
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window



